Ogilvy Health Appoints Health Tech Agency Leader Dan Blomfield as MD of Its Singapore Hub

Ogilvy Health has appointed health tech leader Dan Blomfield as managing director of its Singapore operations. The move comes as a response to the growing importance of Singapore as a hub for pharmaceutical and health tech companies in the APAC region – and further strengthens the agency’s ability to innovate in one of the world’s most progressive, tech- led healthcare markets.

Reporting into WPP Health Practice International CEO, Claire Gillis, Dan will be responsible for expanding the business in Singapore, working with local and regional clients to develop creative solutions to their broad communications challenges. Dan has a long history of unlocking innovation for healthcare clients, with a diverse mix of global and start-up agency experience across EU and APAC healthcare communications.

Prior to joining Ogilvy Health, Dan was client services director for MIMS, Asia’s largest HCP network and medical communications company. He previously worked in a similar role for Incuna, a health tech agency headquartered in the UK and Singapore, focussed on blending technology with scientific insights and compliance.

Dan will leverage these global and APAC Rx digital insights across all of Ogilvy Health in Singapore’s client partnerships, with a vision to establish the agency as the region’s leader in strategic and creative scientific and medical communications.

Dan Blomfield comments: “The healthcare system in Singapore is incredibly forward thinking, investing heavily in technology to tailor innovative approaches to managing and treating disease. As access to digital services becomes ubiquitous, the creative application of data, technology and deep understanding of scientific communications will play a major role in accelerating health improvement. I’m looking forward to leveraging the rich creative talent of the WPP Health Practice and Ogilvy to ensure Ogilvy Health in Singapore is the vanguard of that change – helping our clients and partners shape new innovations that disrupt healthcare and change lives.”

A passionate health tech advocate, Dan has developed insight-driven communications, online global communities and mobile innovations for top 20 pharma, biotech, foundations and societies with a consistent drive for efficiency and effectiveness.

Claire Gillis, WPP Health Practice International CEO, adds: “This is an exciting appointment for Ogilvy Health and WPP Health Practice. Singapore is a powerful gateway to the APAC region for multinational pharmaceutical companies – and a hotbed for health technology and disruptive innovation. Dan’s proven track record as a disruptor, along with his health tech experiences in Europa and APAC, significantly strengthens our offer to clients in Singapore and will help us innovate and grow in this important region.”